Skip to main content
Top
Published in: Molecular Cancer 1/2013

Open Access 01-12-2013 | Research

Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms

Authors: Dhruv Kumar, Sharmila Shankar, Rakesh K Srivastava

Published in: Molecular Cancer | Issue 1/2013

Login to get access

Abstract

Background

Autophagy is an indispensable lysosomal self-digestion process involved in the degradation of aggregated proteins and damaged organelles. Autophagy is associated with the several pathological processes, including cancer. Cancer stem cells (CSCs) play significant roles in cancer initiation, progression and drug resistance. Recent studies have demonstrated the antitumor activities of plant-derived chemopreventive agent rottlerin (Rott). However, the molecular mechanism by which Rott induces autophagy in breast CSCs has not been investigated.

Results

The objectives of this study were to examine the molecular mechanism by which Rott induces autophagy which leads to apoptosis in breast CSCs. Treatment of breast CSCs with Rott for 24 h resulted in a concentration dependent induction of autophagy, followed by apoptosis as measured by flow cytometry. Electron microscopy confirmed the presence of autophagosomes in Rott treated breast CSCs. Western blot analysis showed that Rott treatment increased the expression of LC3, Beclin-1 and Atg12 that are accumulated during autophagy. Prolonged exposure of breast CSCs to Rott caused apoptosis which was associated with the suppression of phosphorylated Akt and mTOR, upregulation of phosphorylated AMPK, and downregulation of anti-apoptosis Bcl-2, Bcl-XL, XIAP and cIAP-1. Knock-down of Atg7 or Beclin-1 by shRNA inhibited Rott-induced autophagy at 24 h. Our study also demonstrates that pre-treatment of breast CSCs with autophagosome inhibitors 3-methyladenine and Bafilomycin, as well as protein synthesis inhibitor cycloheximide inhibited Rott-induced autophagy and apoptosis. Rott induces autophagy via extensive cytoplasmic vacuolization in breast CSCs. Molecular docking results between C2-domain of protein kinase C-delta and Rott indicated that both hydrogen bonding and hydrophobic interactions contributed significantly for ligand binding with minimum binding affinity of ≈ 7.5 Kcal/mol. Although, autophagy inhibitors suppress the formation of cytoplasmic vacuolization and autophagy in breast CSCs, the potency of Rott to induce autophagy and apoptosis might be based on its capability to activate several pathways such as AMPK and proteasome inhibition.

Conclusions

A better understanding of the relationship between autophagy and apoptosis would eventually allow us to discover novel drugs for the treatment of breast cancer by eliminating CSCs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yue ZY, Jin SK, Yang CW, Levine AJ, Heintz N: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA. 2003, 100: 15077-15082. 10.1073/pnas.2436255100PubMedCentralCrossRefPubMed Yue ZY, Jin SK, Yang CW, Levine AJ, Heintz N: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA. 2003, 100: 15077-15082. 10.1073/pnas.2436255100PubMedCentralCrossRefPubMed
2.
go back to reference Deretic V, Delgado M, Vergne I, Master S, De Haro S, Ponpuak M, Singh S: Autophagy in Immunity against mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy. Autophagy. 2009, 335: 169-188. Deretic V, Delgado M, Vergne I, Master S, De Haro S, Ponpuak M, Singh S: Autophagy in Immunity against mycobacterium tuberculosis: a model system to dissect immunological roles of autophagy. Autophagy. 2009, 335: 169-188.
4.
go back to reference Maiuri MC, Zalckvar E, Kimchi A, Kroemer G: Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007, 8: 741-752. 10.1038/nrm2239CrossRefPubMed Maiuri MC, Zalckvar E, Kimchi A, Kroemer G: Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007, 8: 741-752. 10.1038/nrm2239CrossRefPubMed
6.
go back to reference Talloczy Z, Jiang WX, Virgin HW, Leib DA, Scheuner D, Kaufman RJ, Eskelinen EL, Levine B: Regulation of starvation- and virus-induced autophagy by the eIF2 alpha kinase signaling pathway. Proc Natl Acad Sci U S A. 2002, 99: 190-195. 10.1073/pnas.012485299PubMedCentralCrossRefPubMed Talloczy Z, Jiang WX, Virgin HW, Leib DA, Scheuner D, Kaufman RJ, Eskelinen EL, Levine B: Regulation of starvation- and virus-induced autophagy by the eIF2 alpha kinase signaling pathway. Proc Natl Acad Sci U S A. 2002, 99: 190-195. 10.1073/pnas.012485299PubMedCentralCrossRefPubMed
7.
go back to reference Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S: Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004, 11: 448-457. 10.1038/sj.cdd.4401359CrossRefPubMed Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S: Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ. 2004, 11: 448-457. 10.1038/sj.cdd.4401359CrossRefPubMed
8.
go back to reference Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I: Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 2003, 63: 2103-2108.PubMed Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I: Induction of autophagic cell death in malignant glioma cells by arsenic trioxide. Cancer Res. 2003, 63: 2103-2108.PubMed
9.
go back to reference Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D, Yahalom J: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001, 61: 439-444.PubMed Paglin S, Hollister T, Delohery T, Hackett N, McMahill M, Sphicas E, Domingo D, Yahalom J: A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 2001, 61: 439-444.PubMed
10.
go back to reference Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB: Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005, 120: 237-248. 10.1016/j.cell.2004.11.046CrossRefPubMed Lum JJ, Bauer DE, Kong M, Harris MH, Li C, Lindsten T, Thompson CB: Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell. 2005, 120: 237-248. 10.1016/j.cell.2004.11.046CrossRefPubMed
11.
go back to reference Onodera J, Ohsumi Y: Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J Biol Chem. 2005, 280: 31582-31586. 10.1074/jbc.M506736200CrossRefPubMed Onodera J, Ohsumi Y: Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J Biol Chem. 2005, 280: 31582-31586. 10.1074/jbc.M506736200CrossRefPubMed
12.
go back to reference Baehrecke EH: Autophagy: dual roles in life and death?. Nat Rev Mol Cell Biol. 2005, 6: 505-510. 10.1038/nrm1666CrossRefPubMed Baehrecke EH: Autophagy: dual roles in life and death?. Nat Rev Mol Cell Biol. 2005, 6: 505-510. 10.1038/nrm1666CrossRefPubMed
13.
go back to reference Livesey KM, Tang DL, Zeh HJ, Lotze MT: Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs. 2009, 10: 1269-1279.PubMed Livesey KM, Tang DL, Zeh HJ, Lotze MT: Autophagy inhibition in combination cancer treatment. Curr Opin Investig Drugs. 2009, 10: 1269-1279.PubMed
14.
go back to reference Taguchi-Atarashi N, Hamasaki M, Matsunaga K, Omori H, Ktistakis NT, Yoshimori T, Noda T: Modulation of Local PtdIns3P Levels by the PI Phosphatase MTMR3 Regulates Constitutive Autophagy. Traffic. 2010, 11: 468-478. 10.1111/j.1600-0854.2010.01034.xCrossRefPubMed Taguchi-Atarashi N, Hamasaki M, Matsunaga K, Omori H, Ktistakis NT, Yoshimori T, Noda T: Modulation of Local PtdIns3P Levels by the PI Phosphatase MTMR3 Regulates Constitutive Autophagy. Traffic. 2010, 11: 468-478. 10.1111/j.1600-0854.2010.01034.xCrossRefPubMed
15.
go back to reference Singh BNKD, Shankar S, Srivastava RK: Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol. 2012, 84 (9): 1154-1163. 10.1016/j.bcp.2012.08.007CrossRefPubMed Singh BNKD, Shankar S, Srivastava RK: Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol. 2012, 84 (9): 1154-1163. 10.1016/j.bcp.2012.08.007CrossRefPubMed
16.
go back to reference Kumar D, Shankar S, Srivastava RK: Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett. 2013, S0304-3835 (13): 00714-00723. Kumar D, Shankar S, Srivastava RK: Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K/Akt/mTOR signaling pathway. Cancer Lett. 2013, S0304-3835 (13): 00714-00723.
18.
go back to reference Geng JF, Baba M, Nair U, Klionsky DJ: Quantitative analysis of autophagy-related protein stoichiometry by fluorescence microscopy (vol 182, pg 129, 2008). J Cell Biol. 2008, 183: 1175-1175. 10.1083/jcb.20071111220081120c.PubMedCentralCrossRef Geng JF, Baba M, Nair U, Klionsky DJ: Quantitative analysis of autophagy-related protein stoichiometry by fluorescence microscopy (vol 182, pg 129, 2008). J Cell Biol. 2008, 183: 1175-1175. 10.1083/jcb.20071111220081120c.PubMedCentralCrossRef
19.
go back to reference Gozuacik D, Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004, 23: 2891-2906. 10.1038/sj.onc.1207521CrossRefPubMed Gozuacik D, Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene. 2004, 23: 2891-2906. 10.1038/sj.onc.1207521CrossRefPubMed
20.
go back to reference Nemoto T, Tanida I, Tanida-Miyake E, Minematsu-Ikeguchi N, Yokota M, Ohsumi M, Ueno T, Kominami E: The mouse APG10 homologue, an E2-like enzyme for Apg12p conjugation, facilitates MAP-LC3 modification. J Biol Chem. 2003, 278: 39517-39526. 10.1074/jbc.M300550200CrossRefPubMed Nemoto T, Tanida I, Tanida-Miyake E, Minematsu-Ikeguchi N, Yokota M, Ohsumi M, Ueno T, Kominami E: The mouse APG10 homologue, an E2-like enzyme for Apg12p conjugation, facilitates MAP-LC3 modification. J Biol Chem. 2003, 278: 39517-39526. 10.1074/jbc.M300550200CrossRefPubMed
21.
go back to reference Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y, Yoshimori T: Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol. 2001, 152: 657-667. 10.1083/jcb.152.4.657PubMedCentralCrossRefPubMed Mizushima N, Yamamoto A, Hatano M, Kobayashi Y, Kabeya Y, Suzuki K, Tokuhisa T, Ohsumi Y, Yoshimori T: Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol. 2001, 152: 657-667. 10.1083/jcb.152.4.657PubMedCentralCrossRefPubMed
22.
go back to reference Kourtis N, Tavernarakis N: Autophagy and cell death in model organisms. Cell Death Differ. 2009, 16: 21-30. 10.1038/cdd.2008.120CrossRefPubMed Kourtis N, Tavernarakis N: Autophagy and cell death in model organisms. Cell Death Differ. 2009, 16: 21-30. 10.1038/cdd.2008.120CrossRefPubMed
23.
go back to reference Qu XP, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003, 112: 1809-1820. 10.1172/JCI20039PubMedCentralCrossRefPubMed Qu XP, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest. 2003, 112: 1809-1820. 10.1172/JCI20039PubMedCentralCrossRefPubMed
24.
25.
go back to reference Martelli AM, Evangelisti C, Follo MY, Ramazzotti G, Fini M, Giardino R, Manzoli L, McCubrey JA, Cocco L: Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells. Curr Med Chem. 2011, 18: 2715-2726. 10.2174/092986711796011201CrossRefPubMed Martelli AM, Evangelisti C, Follo MY, Ramazzotti G, Fini M, Giardino R, Manzoli L, McCubrey JA, Cocco L: Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells. Curr Med Chem. 2011, 18: 2715-2726. 10.2174/092986711796011201CrossRefPubMed
26.
go back to reference Singh BN, Kumar D, Shankar S, Srivastava RK: Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol. 2012, 84: 1154-1163. 10.1016/j.bcp.2012.08.007CrossRefPubMed Singh BN, Kumar D, Shankar S, Srivastava RK: Rottlerin induces autophagy which leads to apoptotic cell death through inhibition of PI3K/Akt/mTOR pathway in human pancreatic cancer stem cells. Biochem Pharmacol. 2012, 84: 1154-1163. 10.1016/j.bcp.2012.08.007CrossRefPubMed
27.
go back to reference Shao Y, Gao Z, Marks PA, Jiang X: Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA. 2004, 101: 18030-18035. 10.1073/pnas.0408345102PubMedCentralCrossRefPubMed Shao Y, Gao Z, Marks PA, Jiang X: Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci USA. 2004, 101: 18030-18035. 10.1073/pnas.0408345102PubMedCentralCrossRefPubMed
28.
go back to reference Gonzalez-Polo RA, Niso-Santano M, Ortiz-Ortiz MA, Gomez-Martin A, Moran JM, Garcia-Rubio L, Francisco-Morcillo J, Zaragoza C, Soler G, Fuentes JM: Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells. Toxicol Sci. 2007, 97: 448-458. 10.1093/toxsci/kfm040CrossRefPubMed Gonzalez-Polo RA, Niso-Santano M, Ortiz-Ortiz MA, Gomez-Martin A, Moran JM, Garcia-Rubio L, Francisco-Morcillo J, Zaragoza C, Soler G, Fuentes JM: Inhibition of paraquat-induced autophagy accelerates the apoptotic cell death in neuroblastoma SH-SY5Y cells. Toxicol Sci. 2007, 97: 448-458. 10.1093/toxsci/kfm040CrossRefPubMed
29.
go back to reference Herman-Antosiewicz A, Johnson DE, Singh SV: Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res. 2006, 66: 5828-5835. 10.1158/0008-5472.CAN-06-0139CrossRefPubMed Herman-Antosiewicz A, Johnson DE, Singh SV: Sulforaphane causes autophagy to inhibit release of cytochrome C and apoptosis in human prostate cancer cells. Cancer Res. 2006, 66: 5828-5835. 10.1158/0008-5472.CAN-06-0139CrossRefPubMed
30.
go back to reference Nguyen TM, Subramanian IV, Kelekar A, Ramakrishnan S: Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells. Blood. 2007, 109: 4793-4802. 10.1182/blood-2006-11-059352CrossRefPubMed Nguyen TM, Subramanian IV, Kelekar A, Ramakrishnan S: Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells. Blood. 2007, 109: 4793-4802. 10.1182/blood-2006-11-059352CrossRefPubMed
31.
go back to reference Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T: Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005, 25: 1025-1040. 10.1128/MCB.25.3.1025-1040.2005PubMedCentralCrossRefPubMed Boya P, Gonzalez-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Metivier D, Meley D, Souquere S, Yoshimori T: Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 2005, 25: 1025-1040. 10.1128/MCB.25.3.1025-1040.2005PubMedCentralCrossRefPubMed
32.
go back to reference Luo S, Rubinsztein DC: Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ. 2007, 14: 1247-1250. 10.1038/sj.cdd.4402149CrossRefPubMed Luo S, Rubinsztein DC: Atg5 and Bcl-2 provide novel insights into the interplay between apoptosis and autophagy. Cell Death Differ. 2007, 14: 1247-1250. 10.1038/sj.cdd.4402149CrossRefPubMed
33.
go back to reference Kandala PK, Srivastava SK: Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK. Oncotarget. 2012, 3: 435-449.PubMedCentralCrossRefPubMed Kandala PK, Srivastava SK: Regulation of macroautophagy in ovarian cancer cells in vitro and in vivo by controlling glucose regulatory protein 78 and AMPK. Oncotarget. 2012, 3: 435-449.PubMedCentralCrossRefPubMed
34.
go back to reference Jia L, Dourmashkin RR, Allen PD, Gray AB, Newland AC, Kelsey SM: Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol. 1997, 98: 673-685. 10.1046/j.1365-2141.1997.2623081.xCrossRefPubMed Jia L, Dourmashkin RR, Allen PD, Gray AB, Newland AC, Kelsey SM: Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells. Br J Haematol. 1997, 98: 673-685. 10.1046/j.1365-2141.1997.2623081.xCrossRefPubMed
35.
go back to reference Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, Codogno P, Biard-Piechaczyk M: Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest. 2006, 116: 2161-2172. 10.1172/JCI26185PubMedCentralCrossRefPubMed Espert L, Denizot M, Grimaldi M, Robert-Hebmann V, Gay B, Varbanov M, Codogno P, Biard-Piechaczyk M: Autophagy is involved in T cell death after binding of HIV-1 envelope proteins to CXCR4. J Clin Invest. 2006, 116: 2161-2172. 10.1172/JCI26185PubMedCentralCrossRefPubMed
36.
go back to reference Amaravadi RK, Yu DN, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB: Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 2007, 117: 326-336. 10.1172/JCI28833PubMedCentralCrossRefPubMed Amaravadi RK, Yu DN, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB: Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest. 2007, 117: 326-336. 10.1172/JCI28833PubMedCentralCrossRefPubMed
38.
39.
go back to reference Denmeade SR, Isaacs JT: The SERCA pump as a therapeutic target - Making a “smart bomb” for prostate cancer. Cancer Biol Ther. 2005, 4: 14-22. 10.4161/cbt.4.1.1505CrossRefPubMed Denmeade SR, Isaacs JT: The SERCA pump as a therapeutic target - Making a “smart bomb” for prostate cancer. Cancer Biol Ther. 2005, 4: 14-22. 10.4161/cbt.4.1.1505CrossRefPubMed
40.
go back to reference Hoyer-Hansen M, Jaattela M: Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007, 14: 1576-1582. 10.1038/sj.cdd.4402200CrossRefPubMed Hoyer-Hansen M, Jaattela M: Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ. 2007, 14: 1576-1582. 10.1038/sj.cdd.4402200CrossRefPubMed
41.
go back to reference Hoyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N, Elling F, Rizzuto R: Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell. 2007, 25: 193-205. 10.1016/j.molcel.2006.12.009CrossRefPubMed Hoyer-Hansen M, Bastholm L, Szyniarowski P, Campanella M, Szabadkai G, Farkas T, Bianchi K, Fehrenbacher N, Elling F, Rizzuto R: Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell. 2007, 25: 193-205. 10.1016/j.molcel.2006.12.009CrossRefPubMed
42.
go back to reference Demarchi F, Bertoli C, Copetti T, Tanida I, Brancolini C, Eskelinen EL, Schneider C: Calpain is required for macroautophagy in mammalian cells. J Cell Biol. 2006, 175: 595-605. 10.1083/jcb.200601024PubMedCentralCrossRefPubMed Demarchi F, Bertoli C, Copetti T, Tanida I, Brancolini C, Eskelinen EL, Schneider C: Calpain is required for macroautophagy in mammalian cells. J Cell Biol. 2006, 175: 595-605. 10.1083/jcb.200601024PubMedCentralCrossRefPubMed
43.
go back to reference Green MF, Anderson KA, Means AR: Characterization of the CaMKKβ-AMPK signaling complex. Cell Signal. 2011, 23 (12): 2005-2012. 10.1016/j.cellsig.2011.07.014PubMedCentralCrossRefPubMed Green MF, Anderson KA, Means AR: Characterization of the CaMKKβ-AMPK signaling complex. Cell Signal. 2011, 23 (12): 2005-2012. 10.1016/j.cellsig.2011.07.014PubMedCentralCrossRefPubMed
44.
go back to reference Kim J, Kundu M, Viollet B, Guan KL: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011, 13: 132-U171. 10.1038/ncb2152PubMedCentralCrossRefPubMed Kim J, Kundu M, Viollet B, Guan KL: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011, 13: 132-U171. 10.1038/ncb2152PubMedCentralCrossRefPubMed
45.
go back to reference Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R: Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy. Science. 2011, 331: 456-461. 10.1126/science.1196371PubMedCentralCrossRefPubMed Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R: Phosphorylation of ULK1 (hATG1) by AMP-Activated Protein Kinase Connects Energy Sensing to Mitophagy. Science. 2011, 331: 456-461. 10.1126/science.1196371PubMedCentralCrossRefPubMed
46.
go back to reference Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F: Rottlerin, a Novel Protein-Kinase Inhibitor. Biochem Biophys Res Commun. 1994, 199: 93-98. 10.1006/bbrc.1994.1199CrossRefPubMed Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F: Rottlerin, a Novel Protein-Kinase Inhibitor. Biochem Biophys Res Commun. 1994, 199: 93-98. 10.1006/bbrc.1994.1199CrossRefPubMed
47.
go back to reference Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, Tanida I, Kobayashi H, Sato F, Sato S, Ishikawa KI: Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 2011, 7: 176-187. 10.4161/auto.7.2.14074PubMedCentralCrossRefPubMed Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, Tanida I, Kobayashi H, Sato F, Sato S, Ishikawa KI: Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 2011, 7: 176-187. 10.4161/auto.7.2.14074PubMedCentralCrossRefPubMed
48.
go back to reference Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK: Resveratrol inhibits pancreatic cancer stem cell characteristics in human and kras(G12D) transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One. 2011, 6 (1): e16530- 10.1371/journal.pone.0016530PubMedCentralCrossRefPubMed Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK: Resveratrol inhibits pancreatic cancer stem cell characteristics in human and kras(G12D) transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One. 2011, 6 (1): e16530- 10.1371/journal.pone.0016530PubMedCentralCrossRefPubMed
49.
go back to reference Pappa H, Murray-Rust J, Dekker LV, Parker PJ, McDonald NQ: Crystal structure of the C2 domain from protein kinase C-delta. Structure. 1998, 6: 885-894. 10.1016/S0969-2126(98)00090-2CrossRefPubMed Pappa H, Murray-Rust J, Dekker LV, Parker PJ, McDonald NQ: Crystal structure of the C2 domain from protein kinase C-delta. Structure. 1998, 6: 885-894. 10.1016/S0969-2126(98)00090-2CrossRefPubMed
50.
go back to reference Trott O, Olson AJ: AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010, 31: 455-461.PubMedCentralPubMed Trott O, Olson AJ: AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010, 31: 455-461.PubMedCentralPubMed
51.
go back to reference Azam SS, Abbasi SW: Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines. Theor Biol Med Model. 2013, 10: 63- 10.1186/1742-4682-10-63PubMedCentralCrossRefPubMed Azam SS, Abbasi SW: Molecular docking studies for the identification of novel melatoninergic inhibitors for acetylserotonin-O-methyltransferase using different docking routines. Theor Biol Med Model. 2013, 10: 63- 10.1186/1742-4682-10-63PubMedCentralCrossRefPubMed
52.
go back to reference Kessel D, Reiners JJ, Hazeldine ST, Polin L, Horwitz JP: The role of autophagy in the death of L1210 leukemia cells initiated by the new antitumor agents, XK469 and SH80. Mol Cancer Ther. 2007, 6: 370-379. 10.1158/1535-7163.MCT-05-0386PubMedCentralCrossRefPubMed Kessel D, Reiners JJ, Hazeldine ST, Polin L, Horwitz JP: The role of autophagy in the death of L1210 leukemia cells initiated by the new antitumor agents, XK469 and SH80. Mol Cancer Ther. 2007, 6: 370-379. 10.1158/1535-7163.MCT-05-0386PubMedCentralCrossRefPubMed
53.
go back to reference Basu A: Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med. 2003, 7: 341-350. 10.1111/j.1582-4934.2003.tb00237.xCrossRefPubMed Basu A: Involvement of protein kinase C-delta in DNA damage-induced apoptosis. J Cell Mol Med. 2003, 7: 341-350. 10.1111/j.1582-4934.2003.tb00237.xCrossRefPubMed
54.
go back to reference Zhivotovsky B, Samali A, Gahm A, Orrenius S: Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ. 1999, 6: 644-651. 10.1038/sj.cdd.4400536CrossRefPubMed Zhivotovsky B, Samali A, Gahm A, Orrenius S: Caspases: their intracellular localization and translocation during apoptosis. Cell Death Differ. 1999, 6: 644-651. 10.1038/sj.cdd.4400536CrossRefPubMed
55.
go back to reference Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, Raynaud S, Auberger P: Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res. 2010, 70 (3): 1042-1052. 10.1158/0008-5472.CAN-09-3537CrossRefPubMed Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, Raynaud S, Auberger P: Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res. 2010, 70 (3): 1042-1052. 10.1158/0008-5472.CAN-09-3537CrossRefPubMed
56.
go back to reference Lee YJ, Kim NY, Suh YA, Lee C: Involvement of ROS in Curcumin-induced Autophagic Cell Death. Korean J Physiol Pharmacol. 2011, 15 (1): 1-7. 10.4196/kjpp.2011.15.1.1PubMedCentralCrossRefPubMed Lee YJ, Kim NY, Suh YA, Lee C: Involvement of ROS in Curcumin-induced Autophagic Cell Death. Korean J Physiol Pharmacol. 2011, 15 (1): 1-7. 10.4196/kjpp.2011.15.1.1PubMedCentralCrossRefPubMed
57.
go back to reference Gaytán M, Morales C, Sánchez-Criado JE, Gaytán F: Immunolocalization of beclin 1, a bcl-2-binding, autophagy-related protein, in the human ovary: possible relation to life span of corpus luteum. Cell Tissue Res. 2008, 331 (2): 509-517. 10.1007/s00441-007-0531-2CrossRefPubMed Gaytán M, Morales C, Sánchez-Criado JE, Gaytán F: Immunolocalization of beclin 1, a bcl-2-binding, autophagy-related protein, in the human ovary: possible relation to life span of corpus luteum. Cell Tissue Res. 2008, 331 (2): 509-517. 10.1007/s00441-007-0531-2CrossRefPubMed
58.
go back to reference Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005, 122: 927-939. 10.1016/j.cell.2005.07.002CrossRefPubMed Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005, 122: 927-939. 10.1016/j.cell.2005.07.002CrossRefPubMed
59.
go back to reference Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999, 402: 672-676. 10.1038/45257CrossRefPubMed Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B: Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature. 1999, 402: 672-676. 10.1038/45257CrossRefPubMed
60.
go back to reference Sun WL, Chen J, Wang YP, Zheng H: Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy. 2011, 7: 1035-1044. 10.4161/auto.7.9.16521CrossRefPubMed Sun WL, Chen J, Wang YP, Zheng H: Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development. Autophagy. 2011, 7: 1035-1044. 10.4161/auto.7.9.16521CrossRefPubMed
61.
go back to reference Yang PM, Liu YL, Lin YC, Shun CT, Wu MS, Chen CC: Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 2010, 70 (19): 7699-7709. 10.1158/0008-5472.CAN-10-1626CrossRefPubMed Yang PM, Liu YL, Lin YC, Shun CT, Wu MS, Chen CC: Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. Cancer Res. 2010, 70 (19): 7699-7709. 10.1158/0008-5472.CAN-10-1626CrossRefPubMed
62.
go back to reference Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ: AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009, 30: 2785-2791. 10.1002/jcc.21256PubMedCentralCrossRefPubMed Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ: AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem. 2009, 30: 2785-2791. 10.1002/jcc.21256PubMedCentralCrossRefPubMed
Metadata
Title
Rottlerin-induced autophagy leads to the apoptosis in breast cancer stem cells: molecular mechanisms
Authors
Dhruv Kumar
Sharmila Shankar
Rakesh K Srivastava
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2013
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-12-171

Other articles of this Issue 1/2013

Molecular Cancer 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine